. Validation of ISH and IHC for detection of GHR transcript and protein. (a) Validation of ISH probes using mock-transfected (i, ii) and GHR transfected (iii, iv) HEK cells. HEK cells express endogenous GHR and are not expected to be negative for GHR transcript. Probe sets targeting hGHR (i, iii) and bacterial DAPB (ii, iv) as negative control; (b) Staining of human liver (i, iv, vii, x), colon (ii, v, viii, xi) and kidney (iii, vi, ix, xii) by ISH (top panel (i-vi)) and IHC (bottom panel (vii-xii) using the ISH probes validated in a) and the monoclonal antibody MAB263, respectively. IHC protocol was adapted from "J Clin Endocrinol Metab. 1995 Nov; 80(11):3361-7" including vestastain-HRP (PK-6100, Vector Labs Burlingame, CA, USA) and TSA amplification (NEL700001KT, Perkin Elmer, Skovlunde, Denmark). The two methods of staining (ISH and IHC) show overlapping patterns.
. Correlation between hGHR expression and disease severity. Correlation between hGHR expression (qPCR data) and three measures of disease severity; global MAYO score, histopathological evaluation using the Geboes system and endoscopy. GHR expression correlates inversely with all of them. 
